Novo Nordisk has asked the FDA to dam manufacture of compounded copies of copyright, arguing that it’s far too difficult to do safely. It’s the latest escalation in a brewing war involving pharmaceutical providers and compounders. Marijuana-derived goods: Keep on being illegal less th